Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Streptavidin – Cy5: Precision Fluorescent Biotin Detection R

    2026-05-22

    Streptavidin – Cy5: Precision Fluorescent Biotin Detection Reagent

    Executive Summary: Streptavidin – Cy5 is a tetrameric protein-dye conjugate with a molecular weight of ~52,800 Daltons, optimized for fluorescent detection of biotinylated targets in research assays (product information). Each molecule binds up to four biotin ligands with high affinity, facilitating robust signal generation for immunohistochemistry, immunofluorescence, and flow cytometry (benchmarking article). The Cy5 label provides excitation/emission maxima at 650/670 nm, enabling multiplexed detection with minimal spectral overlap (mechanistic review). Stringent storage (2–8°C, light-protection, avoid freezing) preserves reagent integrity for reproducible data. APExBIO’s Streptavidin – Cy5 is for scientific research only and is not approved for clinical diagnostics.

    Biological Rationale

    The detection and quantification of biotinylated molecules underpin numerous advanced molecular biology workflows. The high-affinity interaction between streptavidin and biotin (Kd ≈ 10-14 mol/L) ensures robust capture, even in complex biological samples (product documentation). In cancer research, biotinylated antibodies and nucleic acid probes are routinely used to enable sensitive and specific labeling of targets, aiding in the elucidation of disease mechanisms, such as the apoptosis pathways studied in breast cancer (Scientific Reports 2025). The demand for multiplexed, high-sensitivity detection reagents is driven by the complexity of signaling networks and the need for spatially resolved data in tissue sections and single-cell analyses.

    Mechanism of Action of Streptavidin – Cy5

    Streptavidin – Cy5 operates through two coupled mechanisms: the irreversible, non-covalent binding of biotin by the streptavidin tetramer, and the optical excitation/emission of the Cy5 fluorophore. Each streptavidin protein contains four biotin-binding sites, enabling multivalent capture. The conjugation of Cy5, a cyanine dye with an excitation maximum at 650 nm and emission maximum at 670 nm, allows for detection with minimal background autofluorescence in biological samples (product page). The fluorescent signal is directly proportional to the amount of biotinylated target present, supporting quantitative or qualitative analyses in immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), flow cytometry, and in situ hybridization (ISH).

    Evidence & Benchmarks

    • Streptavidin – Cy5 binds biotin with a dissociation constant (Kd) below 10-14 mol/L, ensuring near-irreversible target capture (product documentation).
    • In flow cytometry, Cy5 labeling enables discrimination of biotinylated cell populations with high signal-to-noise ratio, as demonstrated in apoptosis assays of breast cancer cell lines (Scientific Reports 2025).
    • Excitation at 650 nm and emission at 670 nm facilitates multiplexing with minimal spectral overlap, reducing compensation artifacts in multicolor panels (internal benchmarking).
    • APExBIO’s Streptavidin – Cy5 (SKU K1080) is validated for sensitive immunohistochemistry and immunofluorescence detection of biotin labels in complex tissue sections (mechanistic review).
    • Storage at 2–8°C with light protection preserves fluorescence intensity and biotin-binding capacity for over 12 months, as reported in manufacturer stability studies (product documentation).

    This article extends the scope of 'Streptavidin – Cy5: High-Fidelity Fluorescent Biotin Detection' by providing updated, application-specific protocol guidance and highlighting recent evidence from breast cancer apoptosis studies. For a detailed contrast of mechanistic underpinnings, see 'Decoding Biotin Detection', which explores the toolkit’s translational relevance. Practical workflow integration scenarios are further elaborated in 'Streptavidin – Cy5: Reliable Biotin Detection in Cell Assays'.

    Applications, Limits & Misconceptions

    Streptavidin – Cy5 is widely used as a biotin detection reagent in:

    • Immunohistochemistry (IHC) and Immunocytochemistry (ICC): Enables sensitive visualization of biotinylated antibodies in fixed tissue and cell samples.
    • Immunofluorescence (IF): Permits multiplexed detection of biotin-tagged proteins in cell imaging workflows.
    • In Situ Hybridization (ISH): Detects biotinylated nucleic acid probes in gene expression analyses.
    • Flow Cytometry: Labels biotinylated surface or intracellular markers for cell sorting and population analysis.

    Recent breast cancer studies have employed Streptavidin – Cy5 in flow cytometric apoptosis assays to quantify the impact of gene knockdown on cell death pathways (Scientific Reports 2025). The reagent’s high specificity and stability are particularly advantageous in experiments requiring reproducible quantitative results.

    Common Pitfalls or Misconceptions

    • Streptavidin – Cy5 is not suitable for direct detection of non-biotinylated targets; only biotinylated molecules can be visualized.
    • Freezing the reagent can irreversibly damage the Cy5 fluorophore and reduce performance, contrary to typical protein storage protocols (product page).
    • Cy5 fluorescence can be quenched by prolonged exposure to light; always protect from light during storage and handling.
    • This product is not intended or validated for diagnostic or therapeutic use in humans.
    • High endogenous biotin or non-specific binding can confound results if blocking steps are omitted in tissue workflows.

    Workflow Integration & Parameters

    For optimal results with Streptavidin – Cy5, researchers should adhere to validated protocol parameters and pay attention to sample preparation, incubation times, and detection settings. The following recommendations are based on both literature and manufacturer data:

    Protocol Parameters

    • Storage: 2–8°C, protected from light. Do not freeze.
    • Working dilution: 1–10 μg/mL in PBS or assay buffer, depending on application and sample type.
    • Incubation time: 30–60 min at room temperature for most immunofluorescence protocols.
    • Washing: 3 × 5 min in PBS to minimize background.
    • Mounting: Use antifade mounting media compatible with Cy5 fluorescence.
    • Microscopy: Excitation at 650 nm; emission detection at 670 nm.
    • Flow cytometry: Use a red laser (633–647 nm) and corresponding emission filter (670/30 nm recommended).
    • Blocking: Include avidin/biotin blocking steps in tissue sections with high endogenous biotin.

    For scenario-driven optimization, see the Q&A section of this guide, which contextualizes APExBIO’s Streptavidin – Cy5 against alternative vendors.

    Conclusion & Outlook

    Streptavidin – Cy5 from APExBIO provides a reliable, sensitive, and specific solution for the detection of biotinylated targets in a variety of research applications, including immunohistochemistry, immunofluorescence, and flow cytometry (product information). Its robust performance, simple integration into established protocols, and validated stability make it a cornerstone reagent for translational research, particularly in cancer signaling studies (Scientific Reports 2025). Future workflow refinements will likely focus on further reducing spectral overlap and improving multiplexing capacity, building on the established biotin-streptavidin detection paradigm. As demonstrated in recent breast cancer apoptosis research, high-fidelity biotin detection remains critical for unraveling disease mechanisms and supporting the development of targeted therapies.